Skip to main content
. 2020 May 4;35(23):e177. doi: 10.3346/jkms.2020.35.e177

Table 1. Baseline clinical and ophthalmologic characteristics of subjects according to response at immediate and 3 months after steroid treatment.

Characteristics Immediate after steroid treatment Three months after steroid treatment
Non-responsive group (n = 30) Responsive group (n = 24) P value Non-responsive group (n = 32) Responsive group (n = 22) P value
Age, yr 48.5 ± 12.3 44.6 ± 12.8 0.263 49.9 ± 11.6 42.1 ± 12.8 0.023
Gender, men 7 (23.3) 11 (45.8) 0.081 10 (31.3) 8 (36.4) 0.695
Body mass index, kg/m2 22.7 ± 2.4 22.8 ± 2.7 0.889 22.67 ± 2.24 22.92 ± 2.95 0.732
Duration of GO, mon 14.6 ± 18.6 13.5 ± 14.9 0.808 15.1 ± 19.4 12.7 ± 12.8 0.616
Thyroid hormone medication 3 (10.0) 1 (4.2) 0.416 4 (12.5) 0 (0.0) 0.085
Never smoker 20 (66.7) 13 (54.2) 0.349 21 (65.6) 12 (54.5) 0.412
Sum of EOM, mm 21.11 ± 4.81 21.03 ± 4.45 0.952 20.91 ± 4.57 21.32 ± 4.77 0.755
TSH, µIU/mL 2.17 ± 4.11 1.38 ± 2.48 0.426 1.94 ± 4.02 1.62 ± 2.54 0.748
Free T4, ng/dL 1.36 ± 0.83 1.32 ± 0.58 0.873 1.38 ± 0.81 1.28 ± 0.58 0.635
Initial TBII, IU/L 21.74 ± 15.65 11.81 ± 9.84 0.008 20.80 ± 15.44 12.20 ± 10.40 0.021
Total cholesterol, mg/dL 200.9 ± 39.0 192.5 ± 46.4 0.485 202.1 ± 41.6 190.2 ± 42.8 0.325
MRD1, mm 3.94 ± 1.51 3.79 ± 1.54 0.725 3.73 ± 1.65 4.08 ± 1.28 0.411
Palpebral fissure, mm 9.56 ± 1.90 9.14 ± 2.48 0.490 9.08 ± 2.20 9.79 ± 2.09 0.240
Proptosis, mm 19.03 ± 2.99 18.50 ± 3.13 0.527 18.33 ± 2.84 19.48 ± 3.26 0.175
Any diplopia 14 (46.7) 13 (54.2) 0.584 15 (46.9) 12 (54.5) 0.580
NOSPECS class II, minimal/moderate/marked, % 23.3/66.7/10.0 0.0/95.8/4.2 0.022 18.8/71.9/9.4 4.5/90.9/4.5 0.219
CAS, 3/ ≥ 4, % 53.3/46.7 37.5/62.5 0.246 53.1/46.9 36.4/63.6 0.225

Data are presented as mean ± standard deviation or number (%).

GO = Graves' ophthalmopathy, EOM = extraocular muscle, TSH = thyroid stimulating hormone, TBII = thyrotropin binding inhibitory immunoglobulin, MRD = margin reflex distance, CAS = clinical activity score.